# One new drug, many connected findings

Diltiazem plus tacrolimus: recognize the toxicity cluster

Andrew Bland, MD, FACP, FAAP · October 19, 2026

[Open visual and zoom](https://urinenephrology.org/visual-reference/case-tacrolimus-toxicity-cluster.html)

Diltiazem inhibits CYP3A and P-glycoprotein, increasing tacrolimus exposure. Tacrolimus toxicity can cause renal vasoconstriction, tremor or headache, impaired potassium excretion, magnesium wasting, hyperglycemia, and hypertension. Other causes of graft dysfunction must still be considered.

## The timeline is a diagnostic tool

Diltiazem can raise tacrolimus exposure through inhibition of CYP3A and P-glycoprotein. Review the medication list by start date, including OTC drugs, supplements, and recent illness. A previously stable tacrolimus dose does not guarantee stable exposure after another drug is added.

## One exposure, several organ effects

Excess tacrolimus can cause renal vasoconstriction and a creatinine rise, neurologic effects such as tremor, impaired potassium excretion with possible normal-gap acidosis, renal magnesium wasting, impaired insulin secretion, and increased blood pressure. The findings form a clue cluster; every feature need not be present.

## Connect without anchoring

Check the timing of the trough sample, kidney-function trend, electrolytes, and other relevant findings. Toxicity can coexist with dehydration, infection, obstruction, or rejection. Contact the transplant team promptly; that team directs tacrolimus and other immunosuppression adjustments.

## Discuss

Does finding a high tacrolimus level exclude every other cause of a rising creatinine?

No. The interaction explains a plausible cluster, but transplant AKI still needs assessment for concurrent hemodynamic problems, infection, obstruction, and rejection as indicated.

## Sources

- [Hebert and Lam: diltiazem increases tacrolimus concentrations](https://pubmed.ncbi.nlm.nih.gov/10410178/)
- [Jones and Morris: tacrolimus–diltiazem pharmacokinetic interaction](https://pubmed.ncbi.nlm.nih.gov/12036394/)
- [Tacrolimus prescribing information: interactions and adverse effects](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca08d4aa-3de2-4a9d-9554-6288e5d36f29)

## Related cases

- [Case 13: The Transplant Tremor](https://urinenephrology.org/2025_UDPA_Lectures_Live/case-based-lectures/cbl-13-the-transplant-tremor.html#case-visual-summary)